We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Marketing Authorisation Holders should review their manufacturing processes to identify and, if found, to mitigate the risk of nitrosamine impurities being present.
Statement follows the eighth meeting of the UK - U.S. SME Dialogues in Belfast, Northern Ireland.
Employment Appeal Tribunal Judgment of Judge Tayler on 12 April 2024.
Explanation of the personal information collected as part of UKHSA's enhanced Yersinia surveillance, how we use it and who we share it with.
Check the tariff classification for peptide nisin standardised with sodium chloride
Sections (3.01 - 3.101) last updated: April 2024.
Use a separate statement of objection form for each Japanese GI product name you object to.
Product Safety Report for Esapharma Movate Steroid Cream presenting a serious chemical risk.
Statement by Ambassador Barbara Woodward at the UN Security Council meeting on Yemen.
Check the tariff classification for agarose beads chemically modified with 10% by weight of protein A.
Statement by Ambassador Barbara Woodward at the UN Security Council meeting on Ukraine.
Information on how UK companies can control risks when doing business in Thailand.
Information for clinicians on diagnosis and notification of Shiga toxin-producing Escherichia coli (STEC) and haemolytic uraemic syndrome (HUS).
Information for British nationals who are victims of rape and sexual assault in Tokelau.
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.